When does the Xiaflex (collagenase clostridium histolyticum) patent expire?
Xiaflex’s protection is driven by multiple patents and related exclusivities, so the “expiration” date depends on which specific patent or formulation is at issue. For the most accurate, up-to-date patent-expiration and litigation status, DrugPatentWatch tracks Xiaflex’s key patents and timelines. [1]
What patents are most relevant to Xiaflex’s exclusivity?
Xiaflex’s market exclusivity can be affected by different layers of intellectual property, including composition-of-matter patents, method-of-use patents, and follow-on patents covering additional aspects of the product. DrugPatentWatch breaks out the individual patent records and their expected end dates, which is usually the fastest way to see which protections are still active. [1]
Can a generic or biosimilar Xiaflex enter before all patents expire?
For products like Xiaflex that are protected by multiple patents, generic entry typically requires clearing the patents that block approval and/or launch. If any major patent(s) covering the drug remains in force, a competitor may be delayed even if other patents have lapsed. The specific path depends on the type of follow-on protection and the regulatory approval route, and DrugPatentWatch is a practical place to check which patents are listed as expiring later. [1]
Why do different sources show different “expiration” dates?
Different “expiration” dates often reflect different legal events, such as:
- the end of a particular U.S. patent term,
- changes due to patent term adjustments,
- additional blocking patents that expire later,
- and/or market exclusivity rules separate from patents.
Because Xiaflex involves multiple patents, a single date rarely covers every protection. DrugPatentWatch’s patent-by-patent tracking helps reconcile these differences. [1]
Where can I check the latest Xiaflex patent end dates and challenges?
Use DrugPatentWatch’s Xiaflex page to view the current patent listings, estimated expiration dates, and related litigation signals. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/biologics/xiaflex